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ABSTRACT 
 
Background: JKN program has stipulated the INA CBGs reimbursement for the payment of 
treatment in referral health facilities, including for chronic renal disease which is a disease burden. 
This study aimed to analyze factors influencing the difference between Indonesian case-based 
group reimbursement and medical cost for patients with chronic renal disease cases in Kasih Ibu 
Hospital, Surakarta. 
Subjects and Method: The study design was an analytic observational with cross sectional 
design. The study was conducted in Kasih Ibu Hospital Surakarta in August-October, 2017. With a 
total of 231 subjects sample which was selected by using proportional random sampling. The 
dependent variable was the difference between Indonesian case-based group reimbursement and 
medical cost. The independent variables were length of stay, type of class, medical treatment/ 
surgery, ICU treatment, and medication use. The data were analyzed using multiple linear 
regression. 
Result: INA CBGs reimbursement (mean= Rp 6,120,000; SD= Rp 2,330,000) paid by BPJS 
Kesehatan was lower than actual hospital’s medical care cost (mean= Rp 7,070,000; SD= Rp 
4,650,000). Factors profitable for hospitals were medical treatments/ surgery (b= 0.032; p= 
0.552). Factors that inflicted financial loss were class 1 care (b= -0.104; p= 0.094), class 2 care (b= 
-0.033; p= 0.590) compared to class 3 care, length of stay (b= -0.541; p<0.001), medication use in 
accordance with national formulation (b= -0.183; p= 0.008) and the use of ICU (b= -0.045; p= 
0.543). Patients who upgraded the class type (mean= Rp 5,526,074; SD= Rp 1,449,621) was higher 
than hospital’s medical cost for class 2 (mean= Rp 3,933,767; SD= Rp 1,887,900). 
Conclusion: Mean of INA CBGs reimbursement on inpatient care of chronic renal disease is 
lower than the mean of hospital’s medical care cost. Length of stay and doctors’ compliance in 
using national medication formulation are important determinants to increase medical care cost. 
Hospital obtains profit from patients who upgrade type of class.  
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BACKGROUND 
Chronic Renal Disease (CRD) is an import-
ant global health issue (KDOQI, 2002). In 
the last ten years the CRD cases are escalat-
ing in Indonesia (IRR, 2007). The soaring 
number of CRD cases and keep on increas-
ing is a disease burden since the social 
economic impact faced by family, society, 
nation and healthcare system. The end-
stage of CRD is called Chronic Renal Fail-
ure which needs help in filtering blood 
called as hemodialysis. The treatment for 
CRD patients related to the increasing me-
dical care cost, 65-77% depends on the 
stage (Brown et al, 1999). The increasing 
prevalence of CRD new cases is followed by 
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the utilization of advanced health facilities 
and the amount of expense should be spent 
for medical care. The increasing cost of 
CRD treatment which is considerable for 
patients and health facilities, requires a sys-
tematic effort that is able to secure society 
also providers from the unexpected finan-
cial burden. 
Hospitals as one of the advanced 
health facilities have calculated the medical 
care cost based on components namely unit 
cost, medical service, non-medical, deve-
lopment plan, and the expected profit. The 
cost is later used as the reimbursement of 
service cost implemented in the hospital. 
Based on the morbidity data of Kasih Ibu 
hospital in 2016 there was an increasing 
number of CRD inpatients care by 35% 
compared to 2015. The indications of CRD 
inpatient care truly vary, especially is 
caused by its complication such as anemia 
with Hb <7 g/dL, extreme shortness of 
breath because of cardiovascular complica-
tion or hypertension heart disease, hyper-
kalemia, dyspepsia from uremia that is 
caused by inadequate dialysis or the failure 
of low protein diet, repairing access for 
dialysis and making a new access since the 
old one is disappear or no longer feasible to 
use. The financing sources for inpatient 
care that are mostly used in Kasih Ibu 
hospital are BPJS Kesehatan with a total of 
53%, followed by out-of-pocket payment 
3%, private-owned insurance 14%, coor-
dination of benefit (COB) with BPJS Kese-
hatan 1%. 
The addition of advanced health faci-
lities which collaborate with BPJS espe-
cially private-owned hospitals in Central 
Java province and Surakarta in particular 
surely turns to a competitor for the existing 
hospitals. It is also indicating that hospitals 
are demanded to be more efficient and 
effective in organizing medical care to be 
able to survive in the competition era 
among hospitals in receiving JKN patients. 
Moreover, it is realized that all citizens are 
obliged to be JKN members in the 
upcoming 2019 (UU No.11/2014). 
During 3 years of JKN implementa-
tion, there are changes upon policies 
namely the amendment of  Health Minis-
ter's Regulation No.52/ 2014 to Health 
Minister’s Regulation No.64 /2016 on the 
subject of The Amendment on Health 
Minister’s Regulation  No.52 on the subject 
of Service Tariff Standard in the Organi-
zation of Health Insurance Program. The 
amendment of Health Minister's Regula-
tion more or less generates uneasiness es-
pecially for hospitals as the provider since 
there are several tariffs that are declining 
yet there are others that are increasing. 
Furthermore, disagreement occurs between 
medical care cost and INA CBG's reimbur-
sement. Kompasiana.com stated that there 
are gaps between hospitals' cost of care and 
CBG’s payment system that results in 
hospitals should endure financial risks 
(Rinawati, 2015). On the other side, Repu-
blika online news stated that unit cost in 
INA CBG's does not cause financial loss to 
the hospitals (Riadi, 2016). Hospitals that 
can compress production cost of medical 
care for certain diagnosis groups hence the 
average cost (unit cost) per patient is lower 
than INA CBG’s reimbursement, may 
obtain profit from CRD patients care by 
means of hemodialysis. In contrast, if unit 
cost per patient of CRD is higher than INA 
CBG's then hospitals will endure the loss.
 
Based on the background it was 
important to study whether there is discre-
pancy or distinction between the average 
cost of CRD inpatient care undergone by 
hospital and the tariff of CRD inpatient care 
determined by BPJS Kesehatan. It was also 
important to study factors that influence 
the distinctions. 
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SUBJECTS AND METHOD 
The study was an analytic observational 
with cross sectional approach. The study 
was conducted in Kasih Ibu Hospital Sura-
karta which was a type B private-owned 
non-teaching hospital. The study was con-
ducted in August–October 2017. There 
were a total of 231 subjects with propor-
tional random sampling technique. Data 
collection was conducted by using observa-
tion on patients’ medical record and costing 
data that has been verified by BPJS Kese-
hatan. INA CBGs’ codes used for chronic 
renal diseases including: N-4-10-I, N-4-10-
II, N-4-10-III, N-4-16-I, N-4-16-II, N-4-16-
III, N-1-12-I, N-1-12-II, N-1-12-III. The 
dependent variable was the difference 
between INA CBGs' reimbursement with 
hospital’s medical care cost for inpatient 
care of chronic renal disease cases. Inde-
pendent variables include type of class, 
length of stay, medical treatments/ surgeri-
es, medication use in accordance with the 
national formulation and the use of ICU. 
Data analysis used multiple linear regres-
sions.
 
 
RESULT 
1. Characteristics of study subjects 
The study result toward the characteristics 
frequency distribution of 200 study sub-
jects showed that there were more male 
than female subjects. Most subjects were 
above 35 years. It could be seen in Table 1. 
Characteristics frequency distribution of 31 
study subjects who upgraded from patients 
of class 3 to class 2 could be seen in Table 2. 
Table 1. Characteristics of the study 
subjects based on age and sex 
categories 
Characteristics N % 
Sex Categories   
Male 105 52.5 
Female 95 47.5 
Age   
20 – 35 years 17 8.5 
≥35 years 183 91.5 
Table 2. Characteristics of study subjects for patients who upgraded the type of 
class from class 3 to class 2 for inpatient care of CRD cases 
Characteristics Category N % 
Sex categories Male 19 61.2 
 Female 12 38.7 
Age 20 – 35 years 3 9.68 
 ≥35 years 28 90.32 
 
Table 3. Description of variables of the study   
Variables n Mean SD Minimum Maximum 
INA CBGs reimbursement (x Rp 1,000,000) 200 6.12 2.33 3.31 12.47 
Hospital cost of care (x Rp1,000,000) 200 7.07 4.65 1.27 38.57 
Length of stay (day) 200 3.71 1.68 1 9 
Difference of tariff (x Rp 1,000,000) 200 -0.96 0.96 -2.61 5.08 
 
2. Univariate Analysis 
Description of univariate study on variables 
of the study explained the general descrip-
tion of each variable of the study that 
consisted of INA CBGs reimbursement, 
hospital’s medical care cost, the difference 
of tariff on inpatient care of CRD cases in 
million rupiah unit, and length of stay in 
days. It can be seen in Table 3. 
Table 3 showed that mean of INA 
CBG’s reimbursement for inpatient care of 
Chronic Renal Disease cases was smaller 
than the mean of medical care cost at Kasih 
Ibu Hospital with tariff difference was 
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minus Rp 960,000. The length of stay 
ranged from 1 day at the minimum and 9 
days at the maximum, with the average 
length of stay was 4 days. 
Categorical data that included the 
type of class, with or without medical treat-
ment/ surgery, the use of ICU and the use 
of medicine in accordance with JKN natio-
nal formulation was presented in Table 4. 
3. Bivariate Analysis 
The bivariate analysis explains about the 
association of one variable with another 
variable. The variables presented were the 
difference between INA CBGs’ reimburse-
ment and hospital’s medical care cost also 
doctors’ compliance in using medicine in 
accordance with JKN National Formula-
tion. It can be seen in Figure 1 and 2. 
Table 4. Description of Variables of the Study 
Variables Category n % 
Type of Class 
 
Class 1 
Class 2 
Class 3 
80 
56 
64 
40 
28 
32 
Level of Severity 
 
Mild 
Moderate 
Severe 
64 
115 
21 
32 
57.5 
10.5 
Medical treatment/ Surgery 
 
Yes 
No 
176 
24 
88 
12 
Use of ICU 
 
Yes 
No 
29 
171 
14.5 
85.5 
The Use of Medicine in accordance 
with National Formulation 
Yes 
No 
178 
21 
89.4 
10.6 
 
 
Figure 1. Scatter plot histogram on the association between 
length of stay and BPJS reimbursement difference  
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Figure 2. Box plot histogram on the association of the use 
of national formulation and BPJS reimbursement difference 
 
Figure 1. explained that there was a 
negative association between length of stay 
with the difference of INA CBGs’ reim-
bursement and hospital’s care cost. Figure 
2 explains that there was a negative asso-
ciation between doctors' compliance in 
using medicine in accordance with the nati-
onal formulation with the difference bet-
ween INA CBGs' reimbursement and hos-
pital’s care cost. 
4. Multivariate Analysis 
The multivariate analysis explains the asso-
ciation of more than one independent 
variables. The analyzed variables include 
the type of class, length of stay (LOS), 
medical treatments/ surgery, the use of ICU 
and the use of medicine in accordance with 
JKN National Formulation. 
Table 5 showed that there was a 
negative association between the difference 
of INA CBGs’ reimbursement and medical 
care cost of CRD case inpatient care with 
the length of stay which was statistically 
significant. Each 1-day addition of the 
length of stay would cause a financial loss 
for the hospital as much as Rp. 1,187,602 
(b= -0.542; CI 95%= -1,436,148 to -
939,055; p<0.001).  
There was negative association bet-
ween the difference of tariff with doctors' in 
compliance in using medicine in accor-
dance with JKN National Formulation (b= -
0.183; 95% CI= -3,844,102 to 579,120 p= 
0.008). Doctors' in compliance in using 
medicine in accordance with National For-
mulation might cause a financial loss for 
the hospital as much as Rp 2,220,789. 
There was a positive association bet-
ween tariff difference with medical treat-
ment/ surgery (b=0.032; 95% CI= -847,876 
to 1,581,720; p= 0.552) however it was 
statistically insignificant. Also with the use 
of ICU (b= -0.045; 95% CI= -1,994,371 to 
1,053,382; p= 0.543). Class 1 care gene-
rated financial loss of Rp 783,260 com-
pared to class 3 (b= -0.104; 95% CI= -1.70 
to 0.13; p= 0.094).  
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Table 5. Result of multiple linear regression analysis on the association between 
the difference of INA CBGs’ reimbursement with medical care cost of CRD cases 
inpatient care and the factors that influence 
Independent Variables b 
95% CI  
p 
Lower Limit Upper Limit 
Constanta 663422 1739775    3066619 0.587 
Class 2 -267983 -1246942 710976 0.590 
Class 1 -783260 -1701513 134993 0.094 
Length of stay (days) -1187602 -1436148 -939055 0.000 
With medical treatment/surgery 366922 -847876 1581720 0.552 
ICU use -470494 -1994371 1053382 0.543 
Medicine administration not fit 
national formulation 
-2211611 -3844102 579120 0.008 
Patients’ age (years) 10990 -21434 43415 0.505 
Complication -1720828 -2820160 -621496 0.002 
Sex categories 259362 -492168 1010894 0.497 
Level of severity 1643003 940418 2345588 0.000 
n observation = 200 
Adjusted R2  = 50.4% 
p < 0.001 
    
 
There was negative association 
between class 2 care (b= -0.03; CI 95%= -
1,246,942 to 710,976; p= 0.590) with tariff 
difference however it was statistically 
insignificant. There was positive association 
between tariff difference with level of seve-
rity and statistically significant (b= 0.27; 
95% CI = 940,418 to 2,345,588; p< 0.001). 
Study subjects who upgraded the type 
of class showed that the mean of INA CBGs' 
tariff of inpatient care of CRD cases for 
class 2 patients was higher than medical 
care cost of class 2 at Kasih Ibu hospital, 
Surakarta. It was explained in Table 6. 
Table 6. Description of variable of the study for patients who upgraded the type of 
class from class 3 to class 2 of inpatient care of CRD cases 
Variables N Mean SD Minimum Maximum 
BPJS reimbursement for class 2 
(rupiah) 
31 5,526,074 1,449,621 3,976,600 8,686,600 
BPJS reimbursement for class 3 31 4,619,135 1,199,608 3,313,800 7,238,900 
Hospital’s care cost for class 2 31 3,933,767 1,887,900 1,345,207 1,345,207 
Difference between hospital’s Care Cost 
for class 2 and BPJS reimbursement for 
class 3 
31 685,358 1,19,.608 -3,372,901 4,732,493 
Difference between BPJS reimburse-
ment for class 2 and class 3 
31 906,938 264,171 303,000 1,447,700 
 
DISCUSSION 
1. INA CBGs’ reimbursement for in-
patient care of CRD compared to 
medical care cost in Kasih Ibu Hos-
pital, Surakarta 
The analysis result found that INA CBGs’ 
reimbursement for inpatient care of CDR 
cases according to the type of class was 
lower than medical care cost in Kasih Ibu 
Hospital Surakarta. The result of the study 
is in line with a study by Hudayani (2016) 
that showed there is a distinction between 
INA CBGs' reimbursement and hospital’s 
real cost in hemorrhagic stroke. In which 
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the total of INA CBGs’ reimbursement is 
lower than hospital’s real cost. 
Calculating the tariff and the cost of 
medical care in healthcare facilities such as 
private-owned hospitals is an important as-
pect in the era of prospective payment of 
current JKN program. Medical care cost 
spent by the hospital to provide treatment 
for patients is truly varied. The variation is 
influenced by the number of resources used 
in particular for inpatient care activities as 
well as the value or price determined by the 
hospital for various service given (Sloan, 
2002). Payment with INA CBGs system 
implies that hospital with the team of doc-
tors should set fix cost and variable cost of 
what must be spent by the hospital for the 
third party (Thabrany, 2014). The determi-
nation is made based on clinical pathways. 
Therefore, it is important for the hospital to 
have and make standard procedure in di-
sease management with clinical pathway, 
particularly for CRD cases. So that hospital 
can perform quality control and cost con-
trol in providing optimal, effective and effi-
cient care. 
 
2. Advantage and disadvantage en-
dured by hospital related to claim 
for INA CBGs reimbursement 
The analysis result found that INA CBGs’ 
reimbursement was lower than hospital’s 
medical care cost for inpatient care of CDR 
case according to the type of class, hence 
hospital endured the financial loss. The 
previous study found that INA CBGs’ reim-
bursement was higher than hospital’s tariff 
regardless the diagnosis/ case of disease 
(Rahayuningrum, 2016). 
Payment of INA CBGs claim gives 
advantages in facilitating the revenue 
calculation for the hospital. The difference 
between advantages and disadvantages of 
INA CBGs' reimbursement implementation 
in private-owned hospitals is generated by 
the various amount of medical care bill for 
each hospital. The amount of bill agreed in 
INA CBGs reimbursement for a certain 
diagnosis and procedure should be agreed 
by all hospitals in a certain region through 
hospital organization which is the local 
Indonesia Hospital Association (PERSI), 
therefore PERSI should improve its role in 
this matter. In addition, one of the factors 
considered in hospital’s annual operational 
budget planning is the amount of profit 
possibly obtained to subsequently develop 
hospital.   
Tamtomo (1995) explained that hos-
pital should be able to maintain its sus-
tainability through surplus or profit without 
neglecting the social functions. Further-
more, as an effort to consistently have com-
petitive profit compare to other healthcare 
providers, the hospital should improve 
cost-effectiveness and cost-effectiveness 
without reducing service quality, having 
data and information flow which help in 
optimizing resources and creating new op-
tions in the service quality improvement 
(Hidayat, 2016). 
3. Association between type of class 
with tariff difference 
The result of the analysis showed that me-
dical care in class 1 and class 2 had a nega-
tive association and statistically come close 
to significant compared to medical care in 
class 3with a growing difference between 
the tariff and hospital’s medical care cost. 
INA CBG’s reimbursement has a sti-
pulated class-based tariff that includes class 
1, class 2, and class 3. In line with Appendix 
of Health Minister’s Regulation No. 64/ 
2016 on the subject of the Amendment on 
Health Minister’s Regulation No. 52/2014 
on the subject of Healthcare Tariff Stan-
dard in the Administration of Health Insu-
rance Program, hence there is tariff diff-
erence in each type of class. The higher the 
type of class is, the bigger amount of INA 
CBGs’ in rupiah will be. It is in line with the 
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tariff of inpatient room at the hospital, the 
higher the type of class is, the more expen-
sive the tariff of inpatient care room will be. 
The difference of inpatient room tariff is 
determined by the facilities, convenience, 
as well as privacy provided by the hospital. 
However, the provided care, medication, as 
well as service-related to disease manage-
ment by doctors, nurses, and other health 
workers are not different. 
4. Association between length of stay 
with tariff difference 
The result of the analysis showed that there 
was a negative relationship and statistically 
significant between the length of stay at 
hospital for CDR cases and the tariff differ-
ence between INA CBGs and hospital me-
dical care cost. Aggarwal et al. (2014) ex-
plained that the increasing length of stay of 
inpatient care for CDR cases will increase 
inpatient medical care cost spent with the 
mean of LOS for CRD cases is 5 up to 6 
days. 
The length of stay for various diag-
nosis is varied and one of the indicators for 
medical care at the hospital which is regu-
larly measured for calculating the level of 
utilization and financial report for policy 
making in management and directors level. 
The ideal length of stay according to Health 
Department in 2015 was 3 – 12 days. In the 
study, the mean of length of stay for CRD 
cases was 4 days. Therefore, from the eco-
nomy aspect, the longer the LOS is meant 
the higher the cost should be spent by the 
hospital since INA CBGs' reimbursement is 
permanent in nature. From the medical as-
pect, the longer the LOS is may show insu-
fficient medical quality since patients 
should be treated longer or it takes a long 
time to recover. Whether the LOS value is 
ideal for certain disease diagnosis can be 
observed if the hospital has implemented 
and possessed Clinical Pathway for every 
disease diagnosis. 
5. Association between medical treat-
ment/ surgery tariff difference 
The analysis result showed that there was 
positive association which was insignificant 
between medical treatment/surgery with 
the tariff difference of INA CBGs’ and 
medical care cost of inpatient care for CRD 
cases at the hospital. In accordance with 
Health Minister’s Regulation No.76/2016 
on the subject of INA CBGs' guidelines in 
JKN implementation their difference in the 
structure of case-group code between 
procedural inpatient and non procedural 
inpatient. Procedural inpatient includes 
inpatient with surgery such as the making 
or installation of vascular access for hemo-
dialysis patients by a cardiothoracic sur-
geon, whereas non-procedural inpatient 
includes care with non-surgery medical 
treatments such as hemodialysis and blood 
transfusion. Thus INA CBGs’ reimburse-
ment has accommodated the increasing 
medical care cost which is higher for proce-
dural inpatient care than non-procedural 
inpatient care. 
6. Association between ICU utiliza-
tion with tariff difference 
The analysis result showed that there was 
negative association which was insignifi-
cant between the use of inpatient care in 
ICU with tariff difference of INA CBGs’ and 
medical care cost for CRD cases at the 
hospital. It different from the previous stu-
dy that showed that there was a significant 
association between ICU care with hos-
pital’s tariff (Rahayuningrum, 2016). Kara-
batsou et al. (2016) explained that the total 
cost of ICU care is greatly influenced by  3 
things namely the length of stay in ICU, di-
sease severity, the need for mechanic venti-
lator and the use of continuous dialysis or 
CRRT (Continous Renal Replacement The-
rapy). Hence it explains that the difference 
of study results may be inflicted by the 
difference of diagnosis, disease severity, 
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and the absence of CRRT facilities at the 
hospital. Therefore, dialysis is generally 
performed with 4-4.5 hours method in ICU 
or in Hemodialysis Unit without consuming 
longer time. 
7. Association between use of medi-
cine in accordance with JKN natio-
nal formulation with tariff differ-
ence 
The analysis result showed that there was a 
negative association which was significant 
between compliance in using medicine by 
National Formulation with tariff difference 
between INA CBGs’ and hospital’s medical 
care cost. It means that the more doctors 
who do not use medicines in accordance 
with National Formulation the greater the 
loss endured by the hospital. 
Based on the Republic of Indonesia 
Health Minister’s Decree No.328/2013 the 
most of the medicines categorized into 
National Formulation are generic medi-
cines. However, in reality, it is difficult 
especially for private-owned hospitals to 
obtain the medicines in compliance with 
National Formulation by means of e-pur-
chasing as it is explained in Health Mini-
ster’s Regulation No.28/2014 on the sub-
ject of medicines procurement for JKN 
patients care. The problem is still becoming 
a hindrance up to now after JKN has pro-
ceeded for more than 3 years. Hence the 
hospitals generally will conduct their own 
medicine procurement independently by 
seeking for generic medicines with prices 
come close to the JKN national formulation 
prices. A study by Kalo et al. (2014) ex-
plains that generic medicines use will in-
crease patients' accessibility to obtain the-
rapy, in addition, to suppress and cut down 
the expenses of pharmacy or medicines 
cost. The similar thing is also being follow-
ed by the policy on JKN National Formula-
tion usage in Indonesia with one of the pur-
pose is to control public healthcare cost. 
Factors that influence the policy consist of 
patients, doctors, pharmacists, and the 
manager of formulation makers (Howard et 
al., 2017). Furthermore, it is explained in 
the above study that Medical Specialists are 
likely to prescribe more for patent medici-
nes. 
It is in accordance with the result of 
the current study that there were still study 
subjects who did not obtain medicines in 
compliance with National Formulation 
(generic medicine) they get the patent 
medicine instead. The reason is that there 
are doctors and pharmacists who perceive 
that generic medicines are not as good as 
the original or patent medicines (Dunne, 
2014). For that it takes education and more 
studies on generic medicine’s effectiveness 
for the value-based medicine thus it can in-
crease the compliance and will of health 
practitioners especially Medical Specialists 
to prescribe generic medicines. 
8. Association between amount of 
cost for patients who upgrade the 
type of class at hospital with tariff 
difference 
The analysis result showed that the mean of 
INA CBGs’ reimbursement of inpatient care 
for CRD cases in class 2 was higher than the 
mean of patients’ medical care cost of class 
2 in Kasih Ibu Hospital Surakarta. It means 
the hospital obtain profit from patients who 
upgrade from class 3 to class 2 of inpatient 
care for CRD cases. The amount of cost 
sharing for patients who upgrade the type 
of class is regulated in Health Minister’s 
Regulation No.64/ 2016. For patients who 
upgrade the type of class from class 3 to 
class 2, the patients should pay the tariff 
difference of INA CBGs for the class they 
occupy, deducted by the tariff of INA CBGs’ 
of class they deserve to be in. 
The limitation of the study among 
others are that the study was conducted 
without considering other factors of the 
Journal of Health Policy and Management (2017), 2(2): 117-127 
https://doi.org/10.26911/thejhpm.2017.02.02.03 
 
126 e-ISSN: 2549-0281 (online) 
cost component, that probably may influ-
ence the medical care cost such as the 
medical fee of medical workers (doctors 
and nurses) and the study was conducted 
without concerning the patients’ satisfact-
ion level toward the care performed in 
Kasih Ibu Hospital, Surakarta. 
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